US5496360A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Implantable cardiac electrode with rate controlled drug delivery
Assignee: Pacesetter Inc
•
Filing: 1994-04-12
•
Granted: 1996-03-05
•
Expires: 2014-04-12
Abstract
Abstract A body implantable electrode with rate controlled drug delivery is disclosed. A body implantable lead is provided for the delivery of stimulation energy to a desired body site includes a drug dispenser carried by the lead which retains a drug to be dispensed at least adjacent the desired body stimulation site. The drug may be one which is intended to counter thrombus formation, fibrosis, inflammation or arrhythmias, for example. The drug may be in liquid or powder form retained in a reservoir carried by the lead. The reservoir is formed as a pump which controls dispensing of the drug using a fluid drawing agent such as a salt.
Inventors
- 👤 Drew A. Hoffmann
- 👤 M. Elizabeth Bush
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 00:30
CPC Classifications
A; A61; A61N; A61N1/00; A61N1/02; A61N1/04; A61N1/05; A61N1/056; A61N1/0565; A61N1/0568
Claims Analysis
Total Claims: 32
Claim 1
Independent Claim
98 words
An implantable device, comprising: an electrode for implantation in a patient, said electrode having a reservoir located within said electrode; an insulated conductor having a distal end and a proximal end and coupled to said electrode at said distal end of said conductor and having a connector at said proximal end of said conductor; at least one therapeutic drug carried in said reservoir; and at least one drawing agent contained in said reservoir, having an ability to draw body fluid into said reservoir for modulating drug delivery rate of said at least one therapeutic drug to body tissue.
Claim 2
Dependent Claim
98 words
An implantable device, comprising: an electrode for implantation in a patient, said electrode having a reservoir located within said electrode; an insulated conductor having a distal end and a proximal end and coupled to said electrode at said distal end of said conductor and having a connector at said proximal end of said conductor; at least one therapeutic drug carried in said reservoir; and at least one drawing agent contained in said reservoir, having an ability to draw body fluid into said reservoir for modulating drug delivery rate of said at least one therapeutic drug to body tissue.
Claim 3
Dependent Claim
11 words
The implantable device of claim 1, wherein said agent is hydrophilic.
Claim 4
Dependent Claim
11 words
The implantable device of claim 1, wherein said agent is lipophilic.
Claim 5
Dependent Claim
22 words
The implantable device of claim 1, wherein more than one said agent is contained in said reservoir to provide different pumping effects.
Claim 6
Dependent Claim
13 words
The implantable device of claim 2 wherein said hydrophilic agent is a salt.
Claim 7
Dependent Claim
13 words
The implantable device of claim 2 wherein said hydrophilic agent is a protein.
Claim 8
Dependent Claim
25 words
The implantable device of claim 1 and further including a polymeric matrix within said reservoir, wherein said drawing agent is impregnated in said polymeric matrix.
Claim 9
Dependent Claim
12 words
The implantable device of claim 7 wherein said polymeric matrix is biodegradable.
Claim 10
Dependent Claim
29 words
The implantable device of claim 2 and further including a polymeric matrix within said reservoir, wherein said hydrophilic agent comprises a hydrophilic species chemically attached to said polymeric matrix.
Claim 11
Dependent Claim
25 words
The implantable device of claim 1 and further including a polymeric matrix within said reservoir, wherein said therapeutic drug is impregnated in said polymeric matrix.
Claim 12
Dependent Claim
12 words
The implantable device of claim 9 wherein said polymeric matrix is biodegradable.
Claim 13
Dependent Claim
14 words
The implantable device of claim 1 wherein said therapeutic drug is in liquid form.
Claim 14
Dependent Claim
72 words
The implantable device of claim 1, wherein said drawing agent is impregnated in a first polymeric matrix, and said therapeutic drug is impregnated in a second polymeric matrix, and said drug and said drawing agent are separated by an impermeable membrane, said first polymeric matrix expanding upon solvation of said drawing agent to press on said drug and said second polymeric matrix with said impermeable membrane, causing said drug to be dispensed.
Claim 15
Dependent Claim
20 words
The implantable device of claim 1 wherein said drug and said drawing agent are mixed together into a polymeric matrix.
Claim 16
Dependent Claim
29 words
The implantable device of claim 1, and further comprising a barrier layer containing a drawing agent which must be dissolved before said drug can be dissolved to begin elution.
Claim 17
Dependent Claim
56 words
A pump for dispensing a therapeutic drug to a patient's body, comprising: a chamber containing a polymeric matrix, a therapeutic drug, and a hydrophilic agent, wherein said hydrophilic agent is embedded in said polymeric matrix; an electrically insulating material forming an outer wall of said chamber; and an electrode forming an inner wall of said chamber.
Claim 18
Dependent Claim
56 words
A pump for dispensing a therapeutic drug to a patient's body, comprising: a chamber containing a polymeric matrix, a therapeutic drug, and a hydrophilic agent, wherein said hydrophilic agent is embedded in said polymeric matrix; an electrically insulating material forming an outer wall of said chamber; and an electrode forming an inner wall of said chamber.
Claim 19
Dependent Claim
18 words
The pump of claim 16 wherein said electrode has a channel from said chamber to said patient's body.
Claim 20
Dependent Claim
88 words
A body implantable lead comprising: an electrode for sensing or stimulation for implantation in a patient's body; an insulated conductor having a distal end and a proximal end and coupled to said electrode at said distal end of said conductor and having a connector at said proximal end of said conductor; and a drug eluting system located within said electrode having at least one therapeutic drug and at least one fluid drawing agent for use as a pump for delivering said at least one therapeutic drug to tissue.
Claim 21
Dependent Claim
88 words
A body implantable lead comprising: an electrode for sensing or stimulation for implantation in a patient's body; an insulated conductor having a distal end and a proximal end and coupled to said electrode at said distal end of said conductor and having a connector at said proximal end of said conductor; and a drug eluting system located within said electrode having at least one therapeutic drug and at least one fluid drawing agent for use as a pump for delivering said at least one therapeutic drug to tissue.
Claim 22
Dependent Claim
22 words
The lead of claim 18, wherein said drug eluting system has a plurality of fluid drawing agents to provide different pumping effects.
Claim 23
Dependent Claim
12 words
The lead of claim 18 wherein said fluid drawing agent is lipophilic.
Claim 24
Dependent Claim
27 words
The body implantable lead of claim 18 and further comprising a polymeric matrix within said electrode, wherein said fluid drawing agent is impregnated in said polymeric matrix.
Claim 25
Dependent Claim
24 words
The lead of claim 18 and further comprising a polymeric matrix within said electrode, wherein said therapeutic drug is impregnated in said polymeric matrix.
Claim 26
Dependent Claim
11 words
The lead of claim 22 wherein said polymeric matrix is biodegradable.
Claim 27
Dependent Claim
44 words
The lead of claim 18 wherein said therapeutic drug and said fluid drawing agent are separated by an impermeable membrane, said fluid drawing agent expanding upon drawing of fluid to press on said drug with said impermeable membrane, causing said drug to be dispensed.
Claim 28
Dependent Claim
43 words
The lead of claim 18, and further comprising a chamber containing said drug and a fluid drawing agent which is embedded in a polymeric matrix, said chamber having an electrically insulating material forming an outer wall and said electrode forming an inner wall.
Claim 29
Dependent Claim
18 words
The lead of claim 25 wherein said electrode has a channel from said chamber to the patient's body,.
Claim 30
Dependent Claim
12 words
The lead of claim 25 wherein said electrically insulating material is semipermeable.
Claim 31
Dependent Claim
116 words
A drug eluting system for use in an implantable electrode comprising: a porous electrode; an outer chamber formed by a semipermeable electrically insulating material and containing at least one therapeutic drug; an inner chamber formed by a semipermeable membrane and containing a hydrophilic agent for use as an osmotic pump for delivering said at least one therapeutic drug to tissue; an impermeable membrane separating said outer chamber from said inner chamber, said semipermeable membrane allowing body fluid to pass through to said inner chamber, said hydrophilic agent expanding upon hydration to press on said drug with said impermeable membrane, causing said drug to be dispensed through said semipermeable electrically insulating material and through said porous electrode.
Claim 32
Dependent Claim
116 words
A drug eluting system for use in an implantable electrode comprising: a porous electrode; an outer chamber formed by a semipermeable electrically insulating material and containing at least one therapeutic drug; an inner chamber formed by a semipermeable membrane and containing a hydrophilic agent for use as an osmotic pump for delivering said at least one therapeutic drug to tissue; an impermeable membrane separating said outer chamber from said inner chamber, said semipermeable membrane allowing body fluid to pass through to said inner chamber, said hydrophilic agent expanding upon hydration to press on said drug with said impermeable membrane, causing said drug to be dispensed through said semipermeable electrically insulating material and through said porous electrode.
References Cited (Backward Citations)
US4711251B1
Cited
US4711251A
Cited
US4506680A
Cited
US4606118A
Cited
US4577642A
Cited
US5098425A
Cited
US4960416A
Cited
US5030448A
Cited
US4844099A
Cited
US4940465A
Cited
US4922926A
Cited
US4819662A
Cited
US4819661A
Cited
US5320616A
Cited
US5234424A
Cited
US4976966A
Cited
US5108756A
Cited
US5103837A
Cited
US5002067A
Cited
US4972848A
Cited
US4953564A
Cited
US5020544A
Cited
US5229133A
Cited
US5324280A
Cited
US5154182A
Cited
US5226902A
Cited
US5221278A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-03-05 | 1999-09-04 | 2000-03-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-03-05 | 2003-09-04 | 2004-03-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-03-05 | 2007-09-04 | 2008-03-05 | $7700.00 | Window Closed / Lapsed |